Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Mayumi Yuda"'
Autor:
Rie Kanamori, Nozomi Aoki, Akio Kanazawa, Daisuke Nakamoto, Mayumi Yuda, Nao Makino, Emi Ohata, Nobuyuki Fukui, Hirotake Mori, Hirohide Yokokawa, Toshio Naito
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
BackgroundAs the life expectancy of people living with human immunodeficiency virus (HIV) (PLWH) has improved, chronic disease burden and polypharmacy have increased in PLWH. Simplification of the antiretroviral therapy (ART) regimen for PLWH has bec
Externí odkaz:
https://doaj.org/article/ccb4be09a6db414893e626a892f7148d
Autor:
Rie Kanamori, Futaba Umemura, Kosuke Uemura, Taiju Miyagami, Simon Valenti, Nobuyuki Fukui, Mayumi Yuda, Mizue Saita, Hirotake Mori, Toshio Naito
Publikováno v:
JMIR Formative Research, Vol 8, p e52306 (2024)
BackgroundResearch has found a COVID-19 pandemic–related impact on HIV medical services, including clinic visits, testing, and antiviral therapy initiation in countries including Japan. However, the change in trend for HIV/AIDS testing during the C
Externí odkaz:
https://doaj.org/article/e287dea684814e03b6d6f9aac10a9ebe
Autor:
Toshio Naito, Hirotake Mori, Kazutoshi Fujibayashi, Shinichi Fukushima, Mayumi Yuda, Nobuyuki Fukui, Shotaro Tsukamoto, Mai Suzuki, Keiko Goto-Hirano, Ryohei Kuwatsuru
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract To report the status of switch rates and time-to-switch of antiretroviral therapy (ART) regimens by evaluating anchor drug classes and common switching patterns in Japanese people living with human immunodeficiency virus (HIV, PLWH). This cr
Externí odkaz:
https://doaj.org/article/0e329f25df6d4fa3a2ffb9903dfb0448
Autor:
Toshio Naito, Hirotake Mori, Kazutoshi Fujibayashi, Shinichi Fukushima, Mayumi Yuda, Nobuyuki Fukui, Mai Suzuki, Keiko Goto-Hirano, Ryohei Kuwatsuru
Publikováno v:
Journal of Infection and Chemotherapy. 28:1494-1500
This study aimed to determine whether the current syphilis resurgence in Japan is attributable to incident syphilis in people living with HIV (PLWH).This observational, retrospective, population-based study used data from the Japanese National Databa
Autor:
Hirotake Mori, Nobuyuki Fukui, Shinichi Fukushima, Kazutoshi Fujibayashi, Keiko Goto-Hirano, Mai Suzuki, Toshio Naito, Ryohei Kuwatsuru, Shotaro Tsukamoto, Mayumi Yuda
Publikováno v:
Journal of Infection and Chemotherapy. 28:333-335
Early treatment of HIV infection depends on timely diagnosis, but many persons living with HIV/AIDS (PLWHA) are unaware of their infection. Though many patients seeking medical attention for sexually transmitted diseases have HIV, many patients’ HI
Autor:
Shinichi Fukushima, Keiko Goto-Hirano, Nobuyuki Fukui, Mai Suzuki, Toshio Naito, Ryohei Kuwatsuru, Kazutoshi Fujibayashi, Shotaro Tsukamoto, Mayumi Yuda
Publikováno v:
HIV medicine. 23(5)
OBJECTIVES Comorbidities are associated with a high burden of disease in people living with HIV (PLWH). The objective was to investigate the prevalence of chronic comorbidities and use of co-medications in PLWH in Japan. METHODS This study retrospect
Autor:
Mai Suzuki, Shinichi Fukushima, Keiko Goto-Hirano, Toshio Naito, Ryohei Kuwatsuru, Kazutoshi Fujibayashi, Shotaro Tsukamoto, Mayumi Yuda, Hirotake Mori, Nobuyuki Fukui
To report the status of switch rates and time-to-switch of antiretroviral therapy (ART) regimens by evaluating anchor drug classes and common switching patterns in Japanese people living with human immunodeficiency virus (HIV, PLWH). This cross-secti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a27117f553eb8b87ff039c49ee78e7ca
https://doi.org/10.21203/rs.3.rs-691735/v1
https://doi.org/10.21203/rs.3.rs-691735/v1
Autor:
Toshio Naito, Mai Suzuki, Shinichi Fukushima, Mayumi Yuda, Nobuyuki Fukui, Shotaro Tsukamoto, Kazutoshi Fujibayashi, Keiko Goto-Hirano, Ryohei Kuwatsuru
Publikováno v:
Open Forum Infectious Diseases. 8:S504-S505
Background Comorbidities are associated with a high burden of disease in human immunodeficiency virus (HIV)- positive patients. The objective was to investigate the prevalence of chronic comorbidities and the use of co-medications in HIV-positive pat